Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance-Reference-Cited by-同舟云学术

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

Published:2017-06-15 Issue:7658 Volume:546 Page:431-435
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Shaffer Sydney M.,Dunagin Margaret C.,Torborg Stefan R.,Torre Eduardo A.,Emert Benjamin,Krepler Clemens,Beqiri Marilda,Sproesser Katrin,Brafford Patricia A.,Xiao Min,Eggan Elliott,Anastopoulos Ioannis N.,Vargas-Garcia Cesar A.,Singh Abhyudai,Nathanson Katherine L.,Herlyn Meenhard,Raj Arjun

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature22794.pdf

Reference35 articles.

1. Trunzer, K. et al. Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma. J. Clin. Oncol. 31, 1767–1774 (2013)

2. Garraway, L. A. & Jänne, P. A. Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov. 2, 214–226 (2012)

3. Nazarian, R. et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 468, 973–977 (2010)

4. Krepler, C. et al. Personalized preclinical trials in BRAF inhibitor resistant patient-derived xenograft models identify second-line combination therapies. Clin. Cancer Res. 22, 1592–1602 (2015)

5. Spencer, S. L., Gaudet, S., Albeck, J. G., Burke, J. M. & Sorger, P. K. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459, 428–432 (2009)

Cited by 978 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug tolerance and persistence in bacteria, fungi and cancer cells: Role of non-genetic heterogeneity;Translational Oncology;2024-11

2. Trehalose catalytic shift is an intrinsic factor in Mycobacterium tuberculosis that enhances phenotypic heterogeneity and multidrug resistance;2024-09-13

3. The evolutionary theory of cancer: challenges and potential solutions;Nature Reviews Cancer;2024-09-10

4. Answering open questions in biology using spatial genomics and structured methods;BMC Bioinformatics;2024-09-04

5. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02